- IP address: 126.96.36.199
- Latitude: 47
- Longitude: 8
- Timezone: Europe/Vaduz
Fetching Internal Links
Email address with athera.se
See Web Sites Hosted on 188.8.131.52
We found at least 10 Websites Listing below when search with athera.se on Search Engine
contact; Treating inflammation is the next big breakthrough in fighting cardiovascular disease. Our therapeutic antibody ATH3G10 is a first-in-class candidate. Inflammation in vascular diseases is significant but is not specifically addressed by current therapies. Athera is developing one… learn more. Athera Biotechnologies AB is a dynamic ...
DA: 3 PA: 4 MOZ Rank: 35
Athera Biotechnologies - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +46761938190 Athera is a biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease (“CVD”).
DA: 27 PA: 31 MOZ Rank: 53
Athera.se Site Informations | Host Name 184.108.40.206.bc ...
Athera Biotechnologies - Crunchbase Company Profile & Funding. Crunchbase.com Contact Email [email protected] Phone Number +46761938190 Athera is a biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease (“CVD”).. DA: 5 PA: 15 MOZ Rank: 20
DA: 9 PA: 85 MOZ Rank: 69
Athera (company) | Nordic 9
Get email updates. Create an account to receive dealflow updates from the Nordic startup ecosystem! It is free and it takes 20 seconds! Track intelligence from the Nordics. Don't miss out! Keep track of new investments by creating customised data sets.
DA: 20 PA: 55 MOZ Rank: 5
SwedenBIO - branschorganisationen för life science
For more information, contact: Carina Schmidt, CEO, Athera Biotechnologies AB Phone: +46 (0)76 1938 190, email: [email protected] About Athera Biotechnologies AB The mission of Athera is to address the large unmet need for anti-inflammatory therapeutics in the treatment of cardiovascular disease, with focus on the therapeutic antibody ATH3G10.
DA: 62 PA: 72 MOZ Rank: 25
Athera initiates Phase I trial with its fully human ...
For further information, please contact: Carina Schmidt, Chief Executive Officer, Athera Biotechnologies AB Phone: +46 76 193 81 90 email: [email protected] Bruno Lucidi, Chief Executive Officer, Karolinska Development AB, Phone: +46 72 245 9892, email: [email protected]
DA: 12 PA: 83 MOZ Rank: 43
Resolving inflammation to tackle cardiovascular disease
contact Email: [email protected] Athera Biotechnologies AB athera.se Fig. 1 | The process of efferocytosis. Apoptotic cells withdraw ‘don’t eat me sig’ nals such as CD47 and secretes chemotactic ‘find me sig’ nals that attract phagocytes. Simultaneously, apoptotic cells display new epitopes, including phosphorylcholine
DA: 25 PA: 41 MOZ Rank: 8
Coursework service - GLD Productions
Coursework service. Writing utilizes evidence sincere and in every methods rules coursework service and evaluate neither order investigative. 000 words becomes research a writing 10 across including requires thus of estimated perhaps that time coursework service hundreds and is writing but hours.
DA: 81 PA: 7 MOZ Rank: 51